Search

Your search keyword '"Langley, R."' showing total 1,644 results

Search Constraints

Start Over You searched for: Author "Langley, R." Remove constraint Author: "Langley, R."
1,644 results on '"Langley, R."'

Search Results

152. Epstein-Barr virus and mismatch repair deficiency status differ between oesophageal and gastric cancer: A large multi-centre study

156. Our Unused Influence

161. ATM loss, MSI and survival in the MAGIC trial

165. 2004.

168. LBA-03Neoadjuvant chemotherapy for resectable oesophageal and junctional adenocarcinoma: results from the UK Medical Research Council randomised OEO5 trial (ISRCTN 01852072)

169. Electron number density profiles derived from radio occultation on the CASSIOPE spacecraft

171. Correction of the anion gap for albumin in order to detect occult tissue anions in shock

172. Effect of low-dose aspirin use on survival of patients with gastrointestinal malignancies; an observational study

173. Infections à Candida et infections récidivantes : analyse de 10 études cliniques de phases 2 et 3 de sécukinumab dans le psoriasis modéré à sévère

176. A randomised phase II study of perioperative epirubicin, cisplatin and capecitabine (ECX) ± lapatinib for operable, HER-2 positive gastric, oesophagogastric junctional (OGJ) or lower oesophageal adenocarcinoma: Results from the UK MRC ST03 lapatinib feasibility study (ISRCTN 46020948)

186. ROLE OF TUMOR NECROSIS FACTOR AND INTERFERON GAMMA IN ENDOTOXIN-INDUCED E-SELECTIN EXPRESSION

188. Auswirkung von Secukinumab auf Psoriasis Symptomatik und physikalische Funktionen verglichen mit Placebo und Etanercept bei Probanden mit moderater bis schwerer Plaque-Psoriasis und Psoriasis Arthritis

193. Impact of previous biologic use on the efficacy and safety of brodalumab and ustekinumab in patients with moderate‐to‐severe plaque psoriasis: integrated analysis of the randomized controlled trials AMAGINE‐2 and AMAGINE‐3.

194. Efficacy and safety of continuous every‐2‐week dosing of ixekizumab over 52 weeks in patients with moderate‐to‐severe plaque psoriasis in a randomized phase III trial (IXORA‐P).

195. Matching‐adjusted indirect comparison of efficacy in patients with moderate‐to‐severe plaque psoriasis treated with ixekizumab vs. secukinumab.

196. An Integrated Clinico-Metabolomic Model Improves Prediction of Death in Sepsis

197. Zum Nachweis, zur Bestimmung und Trennung des Zinks

199. Common variants at the MHC locus and at chromosome 16q24.1 predispose to Barrett's esophagus

200. Management of R&D program evaluations: A case study of Canada's energy R&D program

Catalog

Books, media, physical & digital resources